title: Membranoproliferative glomerulonephritis and hepatitis C: effects of interferon-alpha therapy on clinical outcome and histological pattern.
authors.affiliation: Chair of Clinical Surgery, University of Rome Tor Vergata, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Morosetti
authors.forename: G
authors.initials: G
authors.lastname: Sciarra
authors.forename: C
authors.initials: C
authors.lastname: Meloni
authors.forename: G
authors.initials: G
authors.lastname: Palmieri
authors.forename: G
authors.initials: G
authors.lastname: Palombo
authors.forename: M
authors.initials: M
authors.lastname: Taccone Gallucci
authors.forename: C U
authors.initials: CU
authors.lastname: Casciani
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D003449:Cryoglobulinemia / Q000150:complications / Q000473:pathology / Q000628:therapy*; D005260:Female; D015432:Glomerulonephritis, Membranoproliferative / Q000150:complications / Q000473:pathology / Q000628:therapy*; D006526:Hepatitis C / Q000150:complications / Q000473:pathology / Q000628:therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha